Evaluate the effectiveness continuous versus intermittent phototherapy in reduction of level bilirubin level among babies with hyperbilirubinemia in Rajarajeswari Medical College and Hospital at Bangalore

Abstract

Neonatal jaundice is a very common condition in newborns, resulting from the accumulation of
unconjugated bilirubin due to increased red blood cell breakdown and immature liver function. Although
it is usually a normal transitional process, excessive bilirubin levels can become dangerous, as
unconjugated bilirubin is neurotoxic and may lead to kernicterus—a severe condition associated with
neurological damage, hearing loss, and even death.
Phototherapy is the standard and most effective treatment for neonatal hyperbilirubinemia. It works by
using blue light to convert bilirubin in the skin into water-soluble photoisomers that can be excreted
without liver conjugation. This therapy has been widely used for decades and has significantly reduced
the need for exchange transfusion, with no major long-term adverse effects reported.
Both continuous and intermittent phototherapy methods are practiced. While continuous therapy is
commonly used to maximize effectiveness, intermittent therapy can also be equally effective due to the
rapid breakdown of bilirubin and the slower rate at which new bilirubin reaches the skin.
Overall, early identification, monitoring of risk factors, and timely initiation of phototherapy are essential
to prevent complications and ensure better neonatal outcomes.